Prodrugs of anthracyclines for use in antibody-directed enzyme prodrug therapy
…, B Renoux, S Andrianomenjanahary…
Index: Florent, Jean-Claude; Dong, Xia; Gaudel, Gilbert; Mitaku, Sofia; Monneret, Claude; Gesson, Jean-Pierre; Jacquesy, Jean-Claude; Mondon, Martine; Renoux, Brigitte; Andrianomenjanahary, Solo; Michel, Sylvie; Koch, Michel; Tillequin, Francois; Gerken, Manfred; Czech, Joerg; Straub, Rainer; Bosslet, Klaus Journal of Medicinal Chemistry, 1998 , vol. 41, # 19 p. 3572 - 3581
Full Text: HTML
Citation Number: 86
Abstract
A series of new prodrugs of daunorubicin and doxorubicin which are candidates for antibody- directed enzyme prodrug therapy (ADEPT) is reported. These compounds (25a, b, c and 32a, b, c) have been designed to generate cytotoxic drugs after activation with β- glucuronidase. As expected, recovery of the active drug was observed after enzymatic cleavage by Escherichia coli β-glucuronidase as well as by a fusion protein which has ...
Related Articles:
An expeditious approach for the synthesis of β-hydroxy aryl α-amino acids present in vancomycin
[Rama Rao; Chakraborty; Laxma Reddy; Srinivasa Rao Tetrahedron Letters, 1994 , vol. 35, # 28 p. 5043 - 5046]
Synthesis and spectroscopic data of chlorinated 4-hydroxybenzaldehydes
[Knuutinen, Juha S.; Kolehmainen, Erkki T. Journal of Chemical & Engineering Data, 1983 , vol. 28, # 1 p. 139 - 141]
Prodrugs of anthracyclines for use in antibody-directed enzyme prodrug therapy
[Journal of Medicinal Chemistry, , vol. 41, # 19 p. 3572 - 3581]